Last $5.63 USD
Change Today +0.18 / 3.30%
Volume 2.1M
OREX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Stuttgart
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark D. Booth

Chief Commercial Officer, Orexigen Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 18 board members in 2 different organizations across 4 different industries.

See Board Relationships
54$1,281,314
As of Fiscal Year 2013

Background*

Mr. Mark D. Booth has been the Chief Commercial Officer of Orexigen Therapeutics, Inc. since August 2009. Mr. Booth served as President of Takeda Pharmaceuticals North America Inc. (TPNA) since August 2002 and also served as its Executive Vice President. He has over 25 years of commercial and business development experience. He held senior leadership positions in sales, operations and product development. Prior to joining TPNA, Mr. Booth served as General Manager and ...

Read Full Background

Corporate Headquarters*

3344 North Torrey Pines Court
La Jolla, California 92037

United States

Phone: 858-875-8600
Fax: 858-875-8650

Board Members Memberships*

Director

Education*

BS
Northern Illinois University
MBA
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Salary$296,000
Total Annual Compensation$296,000

Stock Options*

All Other Compensation$8,326
Exercised Options114,767
Exercised Options Value$632,070
Exercisable Options490,422
Unexercisable Options663,502
Total Value of Options$632,070
Total Number of Options1,268,691

Total Compensation*

Total Annual Cash Compensation$467,126
Total Short Term Compensation$296,000
Other Long Term Compensation$8,326
Total Calculated Compensation$1,281,314
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OREX:US $5.63 USD +0.18

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXIGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.